Xanax and Depakene drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Xanax (alprazolam) and Depakene (valproic acid). Common drug interactions include atrioventricular block among females and drug abuse among males.
The phase IV clinical study analyzes what interactions people have when they take Xanax and Depakene. It is created by eHealthMe based on reports of 97 people who take the same drugs from the FDA, and is updated regularly.
What is Xanax?
Xanax has active ingredients of alprazolam. It is often used in stress and anxiety. eHealthMe is studying from 135,347 Xanax users. Check the latest studies of Xanax.
What is Depakene?
Depakene has active ingredients of valproic acid. It is often used in epilepsy. eHealthMe is studying from 14,776 Depakene users. Check the latest studies of Depakene.
97 people who take Xanax and Depakene together, and have interactions are studied.

What are the common drug interactions of Xanax and Depakene, by gender? *:
female:
- Atrioventricular block (heart block)
- Balance disorder
- Blood lactate dehydrogenase increased
- Blood pressure decreased
- Bradycardia (abnormally slow heart action)
- Bradykinesia (decreased bodily movement. it is associated with basal ganglia diseases)
- Bradyphrenia (neurological term referring to the slowness of thought common to many disorders of the brain)
- Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle)
- Cerebral atrophy (decrement in size of brain)
- Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
male:
- Drug abuse
- Somnolence (a state of near-sleep, a strong desire for sleep)
- Heart rate increased
- Hyperthermia (body temperature greatly above normal)
- Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
- Malaise (a feeling of general discomfort or uneasiness)
- Methaemoglobinaemia (a disorder characterized by the presence of a higher than normal level of methemoglobin in blood)
- Neonatal disorder (disease of neonates)
- Overdose
- Sleep disorder
What are the common drug interactions of Xanax and Depakene, by age (0-1 to 60+)? *:
0-1:
- Agitation neonatal (people with depression, obsessive-compulsive disorder, post viral fatigue syndrome, schizophrenia, bipolar i disorder)
- Foetal arrhythmia (abnormal rate or rhythm of the foetus heartbeat)
- Gastrointestinal disorder (functional problems of gastrointestinal tract)
- Irritability
- Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
- Neonatal disorder (disease of neonates)
- Premature baby
- Sleep disorder
- Tremor neonatal (excited neuromuscular activity of newborns)
2-9:
n/a
10-19:
n/a
20-29:
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
- Multiple drug overdose intentional
- Somnolence (a state of near-sleep, a strong desire for sleep)
- Drug exposure during pregnancy
- Leukopenia (less number of white blood cells in blood)
- Neutropenia (an abnormally low number of neutrophils)
30-39:
- Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
- Drug abuse
- Methaemoglobinaemia (a disorder characterized by the presence of a higher than normal level of methemoglobin in blood)
- Overdose
- Abortion induced (medically referred abortion)
- Asthenia (weakness)
- Balance disorder
- Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
- Dyspnoea (difficult or laboured respiration)
- Fall
40-49:
- Malaise (a feeling of general discomfort or uneasiness)
- Somnolence (a state of near-sleep, a strong desire for sleep)
- Tachycardia (a heart rate that exceeds the range of 100 beats/min)
- Abdominal abscess (collection of pus in abdomen)
- Alanine aminotransferase increased
- Aspartate aminotransferase increased
- Depressed level of consciousness
- General physical health deterioration (weak health status)
- Hemiparesis (weakness on one side of the body)
- Hyperglycaemia (high blood sugar)
50-59:
- Insomnia (sleeplessness)
- International normalised ratio increased
- Logorrhoea (excessive, uncontrollable, or incoherent talkativeness)
- Micturition urgency (urgency to pass the urine)
- Pain in extremity
- Panic reaction
- Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur)
- Parosmia (distortion of the sense of smell, as in smelling odours that are not present)
- Personality change
- Photophobia (extreme sensitivity to light)
60+:
- Thrombocytopenia (decrease of platelets in blood)
- Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
- Transaminases increased
- Tremor (trembling or shaking movements in one or more parts of your body)
- Anticonvulsant drug level increased
- Atrioventricular block (heart block)
- Blood pressure decreased
- Bradycardia (abnormally slow heart action)
- Bradyphrenia (neurological term referring to the slowness of thought common to many disorders of the brain)
- Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle)
What are the existing conditions these people have? *
- Suicide Attempt: 7 people, 7.22%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 5.15%
- Bipolar Disorder (mood disorder): 5 people, 5.15%
* Approximation only. Some reports may have incomplete information.
Do you take Xanax and Depakene?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Xanax and Depakene:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Xanax:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Depakene:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Xanax and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Depakene and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Gupta E, Kunjal R, Cury JD, "Severe hyponatremia due to valproic acid toxicity", Journal of clinical medicine research, 2015 Jan .
- Hwabejire JO, Lu J, Liu B, Li Y, Halaweish I, Alam HB, "Valproic acid for the treatment of hemorrhagic shock: a dose-optimization study", journal of surgical research, 2014 Jan .
- Gupta E, Kunjal R, Cury JD, "Severe hyponatremia due to valproic acid toxicity", Journal of clinical medicine research, 2015 Jan .
- Hwabejire JO, Lu J, Liu B, Li Y, Halaweish I, Alam HB, "Valproic acid for the treatment of hemorrhagic shock: a dose-optimization study", journal of surgical research, 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on alprazolam and valproic acid (the active ingredients of Xanax and Depakene, respectively), and Xanax and Depakene (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Cardiac Failure Chronic and Epilepsy - 3 seconds ago
- Could Aricept cause Ill-Defined Disorder? - 12 seconds ago
- Could Rebif cause Facial Spasm? - 23 seconds ago
- Could Buspirone Hcl cause Withdrawal Syndrome? - 29 seconds ago
- Could Sodium Chloride cause Systemic Lupus Erythematosus? - 40 seconds ago
- Could Darzalex cause Mucosal Inflammation? - 42 seconds ago
- Drug interactions of Abraxane and Naprosyn - 43 seconds ago
- Could Lunesta cause Dyspnea? - 43 seconds ago
- Quercetin-3-Rutinoside vs. Mucinex, side effect and effectiveness comparison - 47 seconds ago
- Drug interactions of Metoprolol Succinate and Lunesta - 49 seconds ago